Shenzhen Bingsheng Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Bingsheng Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include YOUMIAOBEI. The owner is based in Shenzhen City, Guangdong Province.

No. 401, Building A2, 13th Baonan Road,

Longgang Community, Longgang Subdistrict, Longgang District

Shenzhen City, Guangdong Province 518172 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Shenzhen Bingsheng Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Bingsheng Technology Co., Ltd. have?

Shenzhen Bingsheng Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Bingsheng Technology Co., Ltd. file in?

Shenzhen Bingsheng Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Bingsheng Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Bingsheng Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as YOUMIAOBEI. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Bingsheng Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Bingsheng Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.